Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Zexie Tang is a modified Traditional Chinese Medicine (TCM) decoction based on the classic Zexie Tang (Alisma Decoction) originally described in the *Synopsis of Prescriptions of the Golden Chamber* (Jin Gui Yao Lue). It typically consists of *Alisma plantago-aquatica* (Zexie) and *Atractylodes macrocephala* (Baizhu) as core ingredients, with common additions such as *Pinellia ternata*, *Poria cocos*, and *Gastrodia elata*. It is primarily utilized in China for the treatment of vertigo (including Meniere's disease), hypertension, and hyperlipidemia. The formula is designed to 'resolve phlegm and dispel dampness,' which in modern pharmacological terms involves diuretic effects, regulation of inner ear fluid pressure, and lipid-lowering activities. Clinical research suggests it may modulate aquaporin expression and improve metabolic profiles in patients with phlegm-dampness syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei zexie tang.